La mortalidad atribuible al tabaquismo comienza a descender en España

Banegas, José R.; Gañán, Lucía Díez; Enríquez, Jesús González; Álvarez, Fernando; Rodríguez‐Artalejo, Fernando

doi:10.1157/13075847

Cited by 82 publications

(42 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2 In Spain around 150 people die each day due to smoking. 3 As mortality attributable to smoking has begun to decline slightly, 3 due to a reduction in the prevalence of smoking, the level of obesity has increased in Spain. 4 Unfortunately, the correlation between being overweight and smoking is particularly harmful to cardiovascular health.…”

Section: Smoking Assessmentmentioning

confidence: 99%

Effect of Smoking on Body Weight: Longitudinal Analysis of the SUN Cohort

Basterra-Gortari

Forga

Bes–Rastrollo

et al. 2010

Revista Española de Cardiología (English Edition)

View full text Add to dashboard Cite

Introduction and objectives. Our aim was to investigate prospectively the association between two major cardiovascular risk factors: smoking and weight gain.Methods. We prospectively evaluated 7565 individuals taking part in a dynamic cohort study over a median follow-up period of 50 months. Self-reported weight and physical activity levels had been validated previously. The adjusted mean difference in weight gain relative to neversmokers (the reference group) was estimated for different levels of tobacco exposure.Results. After adjusting for age, baseline body mass index, sedentary lifestyle, changes in physical activity level, total energy intake, fiber intake, food consumption between meals, and sugary soft drink, fast food and alcohol consumption, it was found that individuals who stopped smoking during follow-up had a greater relative weight gain: men 1.63 kg (95% confidence interval [CI], 1.07-2.19 kg), and women 1.51 kg (95% CI, 1.11-1.91 kg). In addition, active smokers had a greater weight gain than never-smokers: men 0.49 kg (95% CI, 0.11-0.87 kg), and women 0.36 kg (95% CI, 0.07-0.65 kg).Conclusions. Individuals who stopped smoking during follow-up and active smokers both experienced significantly greater weight gains than never-smokers. This association between cardiovascular risk factors should be taken into account when developing prevention programs. Evolución de los cambios en el peso corporal según hábito tabáquico: análisis longitudinal de la cohorte SUN Introducción y objetivos. El objetivo de este estudio fue evaluar prospectivamente la asociación de dos factores de riesgo cardiovascular, el hábito tabáquico y la ganancia de peso.Métodos. Se evaluó prospectivamente a 7.565 participantes de una cohorte dinámica durante una mediana de seguimiento de 50 meses. El peso y la actividad física declarados fueron validados previamente. Como referencia se usó a los nunca fumadores, calculándose diferencias ajustadas de ganancia media de peso para diferentes exposiciones al tabaco.Resultados. Tras ajustar por edad, índice de masa corporal inicial, sedentarismo, cambios de actividad fí-sica, ingesta energética y de fibra, comidas entre horas, consumo de refrescos, de comida rápida y de alcohol, los participantes que dejaron de fumar durante el seguimiento, presentaron una mayor ganancia relativa de peso: hombres +1,63 kg (intervalo de confianza [IC] del 95%, 1,07 a 2,19); mujeres +1,51 kg (IC 95%, 1,11 a 1,91). Los fumadores activos presentaron también mayor ganancia de peso que los nunca fumadores: hombres +0,49 kg (IC del 95%, 0,11 a 0,87); mujeres +0,36 kg (IC del 95%, 0,07 a 0,65).Conclusiones. Los participantes que dejaron de fumar durante el seguimiento y los fumadores activos experimentaron mayores ganancias de peso que los nunca fumadores. La asociación de estos dos factores de riesgo cardiovascular debe ser tenida en cuenta en los programas de prevención.

show abstract

Section: Smoking Assessmentmentioning

confidence: 99%

Effect of Smoking on Body Weight: Longitudinal Analysis of the SUN Cohort

Basterra-Gortari

Forga

Bes–Rastrollo

et al. 2010

Revista Española de Cardiología (English Edition)

View full text Add to dashboard Cite

show abstract

“…The smoking prevalence in Spain is 27%, despite a significant drop (by five percentage points) observed since 2006 4. Therefore, smoking is still a major cause of health and social care costs faced by Spanish society 5, 6, 7, 8, 9, 10. In the Law 28/2005, the Spanish Council of State highlight that state expenditure to cover the health and social care costs caused by smoking exceed the excise duty levied on tobacco products 11.…”

Section: Introductionmentioning

confidence: 99%

Cost‐effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD

et al. 2018

View full text Add to dashboard Cite

AimsTo assess the cost‐effectiveness of alternative smoking cessation scenarios from the perspective of the Spanish National Health Service (NHS).DesignWe used the European study on Quantifying Utility of Investment in Protection from Tobacco model (EQUIPTMOD), a Markov‐based state transition economic model, to estimate the return on investment (ROI) of: (a) the current provision of smoking cessation services (brief physician advice and printed self‐helped material + smoking ban and tobacco duty at current levels); and (b) four alternative scenarios to complement the current provision: coverage of proactive telephone calls; nicotine replacement therapy (mono and combo) [prescription nicotine replacement therapy (Rx NRT)]; varenicline (standard duration); or bupropion. A rate of 3% was used to discount life‐time costs and benefits.SettingSpain.ParticipantsAdult smoking population (16+ years).MeasurementsHealth‐care costs associated with treatment of smoking attributable diseases (lung cancer, coronary heart disease, chronic obstructive pulmonary infection and stroke); intervention costs; quality‐adjusted life years (QALYs). Costs and outcomes were summarized using various ROI estimates.FindingsThe cost of implementing the current provision of smoking cessation services is approximately €61 million in the current year. This translates to 18 quitters per 1000 smokers and a life‐time benefit–cost ratio of 5, compared with no such provision. All alternative scenarios were dominant (cost‐saving: less expensive to run and generated more QALYs) from the life‐time perspective, compared with the current provision. The life‐time benefit–cost ratios were: 1.87 (proactive telephone calls); 1.17 (Rx NRT); 2.40 (varenicline‐standard duration); and bupropion (2.18). The results remained robust in the sensitivity analysis.ConclusionsAccording to the EQUIPTMOD modelling tool it would be cost‐effective for the Spanish authorities to expand the reach of existing GP brief interventions for smoking cessation, provide pro‐active telephone support, and reimburse smoking cessation medication to smokers trying to stop. Such policies would more than pay for themselves in the long run.

show abstract

“…Most studies used an age range of between 1 and 35 for the calculation of the SAM, with some exceptions 1,2,3,14,22,30,61,63 that work with the over 35 age group. The age range under analysis was not mentioned in some studies.…”

Section: Resultsmentioning

confidence: 99%

<B>Aspectos da mortalidade atribuível ao tabaco</B>: <B>revisão sistemática</B>

Oliveira¹,

Valente²,

Leite³

2008

Rev. Saúde Pública

View full text Add to dashboard Cite

The objective of the article was to assess methodologies published and applied in calculating mortality attributable to smoking. A review of the literature was made for the period 1990 to 2006, in the electronic databases MEDLINE and LILACS. A total of 186 studies were found, which measured mortality based on calculating the smoking-attributable risk. Of these, a total of 41 were selected. The studies that were carried out in the United States and Canada presented a more standard methodology and reported smoking attributable mortality to be 18%-23%, with male mortality being 25%-29% and female mortality 14%-17%. The variations can be attributed to methodological differences and to different estimates of the main tobacco-related illnesses.

show abstract

La mortalidad atribuible al tabaquismo comienza a descender en España

Cited by 82 publications

References 4 publications

Effect of Smoking on Body Weight: Longitudinal Analysis of the SUN Cohort

Effect of Smoking on Body Weight: Longitudinal Analysis of the SUN Cohort

Cost‐effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD

<B>Aspectos da mortalidade atribuível ao tabaco</B>: <B>revisão sistemática</B>

Contact Info

Product

Resources

About